Document Title
ACP Response to the Ways and Means and Energy and Commerce Committees on Bipartisan Medicare Part D Drug Pricing Legislation
Synopsis
ACP sends a response to the Ways and Means and Energy and Commerce committees on the Bipartisan Medicare Part D Drug Pricing legislation.
Keywords
ways and means; energy and commerce; medicare; medicare part D; part d; drug pricing; medications; generic drugs
Creation Date
Modified Date
Pages
9
Document Adobe Metadata
{"CreationDate":"2019-06-07T09:18:14-04:00","Creator":"Microsoft\u00ae Word 2016","Keywords":"ways and means; energy and commerce; medicare; medicare part D; part d; drug pricing; medications; generic drugs","ModDate":"2019-09-30T09:34:52-04:00","Producer":"Microsoft\u00ae Word 2016","Title":"ACP Response to the Ways and Means and Energy and Commerce Committees on Bipartisan Medicare Part D Drug Pricing Legislation","Pages":9,"dc:format":"application\/pdf","dc:creator":"","dc:title":"ACP Response to the Ways and Means and Energy and Commerce Committees on Bipartisan Medicare Part D Drug Pricing Legislation","dc:subject":["ways and means","energy and commerce","medicare","medicare part D","part d","drug pricing","medications","generic drugs"],"xmp:createdate":"2019-06-07T09:18:14-04:00","xmp:creatortool":"Microsoft\u00ae Word 2016","xmp:modifydate":"2019-09-30T09:34:52-04:00","xmp:metadatadate":"2019-09-30T09:34:52-04:00","pdf:producer":"Microsoft\u00ae Word 2016","pdf:keywords":"ways and means; energy and commerce; medicare; medicare part D; part d; drug pricing; medications; generic drugs","xmpmm:documentid":"uuid:3058b883-62b0-4125-8265-05f813652a81","xmpmm:instanceid":"uuid:2e783db4-a89f-4cb2-940f-46f3fcc4454b"}
Document Type Year
2019